Literature DB >> 20625918

IgE-dependent sensitization increases responsiveness to LPS but does not modify development of endotoxin tolerance in mast cells.

Jaciel Medina-Tamayo1, Alfredo Ibarra-Sánchez, Alejandro Padilla-Trejo, Claudia González-Espinosa.   

Abstract

OBJECTIVE: Effects of immunoglobulin E (IgE)-dependent sensitization on the response to bacterial lipopolysaccharide (LPS) were analyzed in mast cells.
METHODS: Murine bone marrow-derived mast cells (BMMCs) were sensitized or not with IgE before stimulation with LPS. TLR4 and co-receptors expression was analyzed by flow cytometry and RT-PCR, TNF-α production by ELISA, IKK and IκB activation by western blot or immunoprecipitation. NFκB nuclear translocation was determined by EMSA.
RESULTS: IgE-sensitized BMMCs secreted larger amounts of TNF-α than non-sensitized cells shortly after LPS challenge. No change in TLR4, CD14 or MD-2 expression was detected after the IgE-dependent sensitization process, whereas TLR4-dependent phosphorylation of IKK and IκB was augmented. IgE-dependent sensitization increased basal NFκB activity. Endotoxin tolerance was not affected by the IgE-dependent sensitization process.
CONCLUSIONS: IgE-induced sensitization primes mast cells for higher response to LPS through pre-activation of NFκB transcription factor. IgE-dependent sensitization does not modify events leading to endotoxin tolerance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20625918     DOI: 10.1007/s00011-010-0230-4

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  36 in total

1.  Vav1 regulates phospholipase cgamma activation and calcium responses in mast cells.

Authors:  T S Manetz; C Gonzalez-Espinosa; R Arudchandran; S Xirasagar; V Tybulewicz; J Rivera
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

2.  LPS-induced upregulation of SHIP is essential for endotoxin tolerance.

Authors:  Laura M Sly; Michael J Rauh; Janet Kalesnikoff; Christine H Song; Gerald Krystal
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

3.  Toll-like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products.

Authors:  P Chowdhury; S H Sacks; N S Sheerin
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

4.  CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes: involvement of NF-kappa B, AP-1, and C/EBP.

Authors:  Mekhine Baccam; So-Youn Woo; Charles Vinson; Gail A Bishop
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

5.  The receptor for immunoglobulin E on rat basophilic leukemia cells: effect of ligand binding on receptor expression.

Authors:  K Furuichi; J Rivera; C Isersky
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

6.  Activation of human lung mast cells by monomeric immunoglobulin E.

Authors:  G Cruse; D Kaur; W Yang; S M Duffy; C E Brightling; P Bradding
Journal:  Eur Respir J       Date:  2005-05       Impact factor: 16.671

7.  A role for the phagosome in cytokine secretion.

Authors:  Rachael Z Murray; Jason G Kay; Daniele G Sangermani; Jennifer L Stow
Journal:  Science       Date:  2005-11-10       Impact factor: 47.728

Review 8.  Development, migration, and survival of mast cells.

Authors:  Yoshimichi Okayama; Toshiaki Kawakami
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

9.  Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo.

Authors:  J W Pierce; R Schoenleber; G Jesmok; J Best; S A Moore; T Collins; M E Gerritsen
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

10.  VAMP-8 segregates mast cell-preformed mediator exocytosis from cytokine trafficking pathways.

Authors:  Neeraj Tiwari; Cheng-Chun Wang; Cristiana Brochetta; Gou Ke; Francesca Vita; Zeng Qi; Juan Rivera; Maria Rosa Soranzo; Giuliano Zabucchi; Wanjin Hong; Ulrich Blank
Journal:  Blood       Date:  2008-01-18       Impact factor: 22.113

View more
  7 in total

1.  Stimulation of nAchRα7 Receptor Inhibits TNF Synthesis and Secretion in Response to LPS Treatment of Mast Cells by Targeting ERK1/2 and TACE Activation.

Authors:  F Guzmán-Mejía; C López-Rubalcava; C González-Espinosa
Journal:  J Neuroimmune Pharmacol       Date:  2017-08-18       Impact factor: 4.147

2.  TLR signaling in mast cells: common and unique features.

Authors:  Hilary Sandig; Silvia Bulfone-Paus
Journal:  Front Immunol       Date:  2012-07-04       Impact factor: 7.561

Review 3.  Epigenetic and transcriptional control of mast cell responses.

Authors:  Silvia Monticelli; Cristina Leoni
Journal:  F1000Res       Date:  2017-11-29

4.  LPS Guides Distinct Patterns of Training and Tolerance in Mast Cells.

Authors:  Marco De Zuani; Chiara Dal Secco; Silvia Tonon; Alessandra Arzese; Carlo E M Pucillo; Barbara Frossi
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

5.  Immunoglobulin E induces VEGF production in mast cells and potentiates their pro-tumorigenic actions through a Fyn kinase-dependent mechanism.

Authors:  Guillermina Yanek Jiménez-Andrade; Alfredo Ibarra-Sánchez; Diana González; Mónica Lamas; Claudia González-Espinosa
Journal:  J Hematol Oncol       Date:  2013-08-02       Impact factor: 17.388

6.  Mutant Huntingtin affects toll-like receptor 4 intracellular trafficking and cytokine production in mast cells.

Authors:  Marian Jesabel Pérez-Rodríguez; Alfredo Ibarra-Sánchez; Abraham Román-Figueroa; Francisca Pérez-Severiano; Claudia González-Espinosa
Journal:  J Neuroinflammation       Date:  2020-03-27       Impact factor: 8.322

Review 7.  Signal Transduction Pathways Activated by Innate Immunity in Mast Cells: Translating Sensing of Changes into Specific Responses.

Authors:  Zyanya P Espinosa-Riquer; Deisy Segura-Villalobos; Itzel G Ramírez-Moreno; Marian Jesabel Pérez Rodríguez; Mónica Lamas; Claudia Gonzalez-Espinosa
Journal:  Cells       Date:  2020-11-04       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.